| ? |
39v-53
|
|
|
unclassified
|
RBRC
|
15
|
St13Gt(39v-53)
|
Gene trap 39v-53
|
suppression of tumorigenicity 13
|
gene trap
|
| ? |
BayGenomics ES cell line RRE034
|
|
|
unclassified
|
MMRRC
|
15
|
St13Gt(RRE034)Byg
|
gene trap RRE034, BayGenomics
|
suppression of tumorigenicity 13
|
gene trap
|
| ? |
BayGenomics ES cell line RRZ104
|
|
|
unclassified
|
MMRRC
|
15
|
St13Gt(RRZ104)Byg
|
gene trap RRZ104, BayGenomics
|
suppression of tumorigenicity 13
|
gene trap
|
| ? |
BayGenomics ES cell line XD088
|
|
|
unclassified
|
MMRRC
|
15
|
St13Gt(XD088)Byg
|
gene trap XD088, BayGenomics
|
suppression of tumorigenicity 13
|
gene trap
|
| ? |
BayGenomics ES cell line XL075
|
|
|
unclassified
|
MMRRC
|
15
|
St13Gt(XL075)Byg
|
gene trap XL075, BayGenomics
|
suppression of tumorigenicity 13
|
gene trap
|
| ? |
C57BL/6N-St13Gt(IST11113B7)Tigm
|
|
|
unclassified
|
TIGM
|
15
|
St13Gt(IST11113B7)Tigm
|
gene trap IST11113B7, Texas A&M Institute for Genomic Medicine
|
suppression of tumorigenicity 13
|
gene trap
|
| ? |
C57BL/6N-St13Gt(IST12606D6)Tigm
|
|
|
unclassified
|
TIGM
|
15
|
St13Gt(IST12606D6)Tigm
|
gene trap IST12606D6, Texas A&M Institute for Genomic Medicine
|
suppression of tumorigenicity 13
|
gene trap
|
| ? |
CMHD ES cell lline GT-318H01
|
|
|
unclassified
|
CMMR
|
15
|
Gt (318H01) Cmhd
|
gene trap 318H01, Centre for Modeling Human Disease
|
suppression of tumorigenicity 13
|
gene trap
|
| ? |
CMHD ES cell lline GT-468H9
|
|
|
unclassified
|
CMMR
|
15
|
Gt (468H9) Cmhd
|
gene trap 468H9, Centre for Modeling Human Disease
|
suppression of tumorigenicity 13
|
gene trap
|
| ? |
SIGTR ES cell line AD0014
|
|
|
unclassified
|
MMRRC
|
15
|
St13Gt(AD0014)Wtsi
|
gene trap AD0014, Wellcome Trust Sanger Institute
|
suppression of tumorigenicity 13
|
gene trap
|
| ? |
SIGTR ES cell line XP0114
|
|
|
unclassified
|
MMRRC
|
15
|
St13Gt(XP0114)Wtsi
|
gene trap XP0114, Wellcome Trust Sanger Institute
|
suppression of tumorigenicity 13
|
gene trap
|
| ? |
SIGTR ES cell line XP0131
|
|
|
unclassified
|
MMRRC
|
15
|
Gt(XP0131)Wtsi
|
gene trap XP0131, Wellcome Trust Sanger Institute
|
suppression of tumorigenicity 13
|
gene trap
|
| ? |
St13tm1a(KOMP)Wtsi
|
|
|
mutant strain
|
KOMP
|
15
|
St13tm1a(KOMP)Wtsi
|
targeted mutation 1a, Wellcome Trust Sanger Institute
|
suppression of tumorigenicity 13
|
targeted mutation
|